Researcher, University of North Carolina at Chapel Hill
Appears in 1 story
Lead author of first randomized trial of semaglutide for alcohol use disorder
Drugs designed to control blood sugar and shrink waistlines may also quiet the cravings that drive addiction. A study of more than 600,000 United States veterans, published March 4 in The BMJ, found that people taking GLP-1 medications were 14 percent less likely to develop a new substance use disorder and, if they already had one, experienced 50 percent fewer substance-related deaths and 39 percent fewer overdoses.
Updated Mar 6
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
